Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank55
5Y CAGR-44.5%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
-44.5%/yr
Long-term compound
Percentile
P55
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 22.63% |
| 2024 | -20.36% |
| 2023 | 1184.09% |
| 2022 | -113.14% |
| 2021 | -38.80% |
| 2020 | 431.33% |
| 2019 | -162.51% |
| 2018 | 27.71% |
| 2017 | 1356.19% |
| 2016 | 23.61% |